AI-Enhanced RAIN Protocol: A Systematic Approach to Optimize Drug Combinations for Rectal Neoplasm Treatment

Nasrin Dashti,Ali Akbar Kiaei,Mahnaz Boush,Behnam Gholami-Borujeni,Alireza Nazari

DOI: https://doi.org/10.1101/2024.05.28.596215

2024-06-02

Abstract:Background: Rectal cancers, or rectal neoplasms, are tumors that develop from the lining of the rectum, the concluding part of the large intestine ending at the anus. These tumors often start as benign polyps and may evolve into malignancies over several years. The causes of rectal cancer are diverse, with genetic mutations being a key factor. These mutations lead to uncontrolled cell growth, resulting in tumors that can spread and damage healthy tissue. Age, genetic predisposition, diet, and hereditary conditions are among the risk factors. Treating rectal cancer is critical to prevent severe health issues and death. Untreated, it can cause intestinal blockage, metastasis, and deteriorate the patients quality of life. Effective treatment hinges on finding the right drug combinations to improve therapeutic outcomes. Given the intricacies of cancer biology, treatments often combine surgery, chemotherapy, and radiation, with drugs chosen to target different tumor growth mechanisms, aiming to reduce the tumor and limit side effects. The continuous advancement in cancer treatments highlights the need for ongoing research to discover new drug combinations, offering patients improved recovery prospects and a better quality of life. This background encapsulates a detailed yet succinct understanding of rectal neoplasms, their origins, the urgency of treatment, and the quest for effective drug therapies, paving the way for discussions on treatment advancements and patient care impacts. Method: This study employed the RAIN protocol, comprising three steps: firstly, utilizing the GraphSAGE model to propose drug combinations for rectal neoplasm treatment Each node in the graph model is a drug or a human gene/protein that acts as potential target for Adenocarcinoma, and the edges are P-values between them; secondly, conducting a systematic review across various databases including Web of Science, Google Scholar, Scopus, Science Direct, PubMed, and Embase, with NLP investigation; and thirdly, employing a meta-analysis network to assess the efficacy of drugs and genes in relation to each other. All implementations was conducted using Python software. Result: The study evaluated the efficacy of Oxaliplatin, Leucovorin, and Capecitabine in treating Rectal Neoplasms, confirming their effectiveness through a review of 30 studies. The p-values for individual drugs were 0.019, 0.019, and 0.016 respectively, while the combined use of all three yielded a p-value of 0.016. Conclusion: Given the significance of rectal neoplasms, policymakers are urged to prioritize the healthcare needs of affected individuals. Utilizing artificial intelligence within the RAIN protocol can offer valuable insights for tailoring effective drug combinations to better address the treatment and management of rectal neoplasms patients.

Bioinformatics

What problem does this paper attempt to address?

This paper presents a protocol called the AI-Enhanced RAIN (Rectal cancer AI-optimized combination Identification) that aims to optimize drug combinations for the treatment of rectal tumors. The background of the study emphasizes the severity of rectal cancer, which requires targeted drug therapy due to uncontrolled cell growth caused by genetic mutations. The RAIN protocol combines the GraphSAGE model and systematic reviews to identify effective treatment combinations by analyzing the relationship between drugs and genes.

In the methodology section, the study follows three steps: firstly, the application of the GraphSAGE model to propose drug combinations; secondly, conducting systematic literature reviews, including searches of multiple databases; and finally, using meta-analysis network to evaluate the effects of drugs and genes. The research results demonstrate the effectiveness of the combination of oxaliplatin, calcium folinate, and capecitabine in the treatment of rectal tumors.

The conclusion calls for policy-makers to address the medical needs of rectal tumor patients and utilize AI-driven protocols like RAIN to improve treatment effectiveness and patient quality of life. The paper also discusses the role of relevant human genes, such as TRNAG1, TRG-TCC1-1, TRG-GCC2-4, TRG-CCC2-1, LARS, SCRT1, CEACAM5, ZNF135, ZNF77, PORCN, TRG-GCC3-1, KRAS, and CCL20, in rectal tumors and their significance as potential therapeutic targets.